In addition, AR-positive, androgen-sensitive VCaP prostate-cancer cells transiently overexpressing OLFM4 displayed reduced expression of SHH and GLI at the mRNA level but not the protein level (Supplementary Fig. S3). This evidence concerns the gene AR and prostate carcinoma.